HOUSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today certain year-end tax reporting information for its 2024 distributions.

With its strong overall performance, VinCSS earns Frost & Sullivan's 2024 Global Transformational Innovation Leadership Award in the IoT security industry. It is also the third consecutive time VinCSS ...

ATLANTA, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ended December 31, 2024 on Thursday, February 27, 2025 ...

DAYTONA BEACH, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE: BRO) announces that the board of directors has declared a regular quarterly cash dividend of $0.15 per share. The ...

In the transaction, qualified institutional buyers purchased $442.4 million of asset-backed notes secured by $462.5 million in automobile receivables originated by CPS. The sold notes, issued by CPS ...

Image 1 Coherent FACTOR Series fiber-coupled diode laser pumps. PITTSBURGH, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. ...

FREEHOLD, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) today announced the tax treatment of its 2024 distributions. The following tables summarize, for income tax ...

Hain Celestial Group (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, plans to issue its financial results for ...

HARTFORD, Conn. and BOSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Eversource Energy will webcast a conference call with financial analysts on Wednesday, February 12, 2025, beginning at 9 a.m. Eastern Time ...

NEENAH, WI, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal first quarter ended December 28, 2024, and guidance for our fiscal second ...

DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its fourth quarter 2024 financial results. The 4Q 2024 financial results and shareholder letter are ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...